CLINICAL_TRIALS ClinicalTrials.gov record update

Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis: A Randomized Controlled Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06484530
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:23.798655+00:00
Published At: 2024-07-03T00:00:00+00:00
Record Updated At: 2024-07-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Tuberculosis (TB)", "Isoniazid Toxicity", "Rifampicin Toxicity", "Pyrazinamide Adverse Reaction", "Ethambutol Toxicity", "NAT2 Slow Acetylator Status", "NAT2 Rapid Acetylator Status", "NAT2 Polymorphism", "N-Acetylcysteine"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-07-03"
protocolSection.identificationModule.nctId: "NCT06484530"
protocolSection.identificationModule.officialTitle: "Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis: A Randomized Controlled Trial"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.